Please login to the form below

Not currently logged in
Email:
Password:

triglycerides

This page shows the latest triglycerides news and features for those working in and with pharma, biotech and healthcare.

Amarin hits jackpot with astonishing heart benefits from fish oil product

Amarin hits jackpot with astonishing heart benefits from fish oil product

While omega-3 fish oils products have been around for many years and help cut triglyceride levels, none have been able to demonstrate significant cardiovascular outcomes benefits for patients until now. ... elevated triglycerides (TGs) between 150-499

Latest news

More from news
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    aureus and Shigellosis. Corporate acquisition. 190. Amarin/ Eddingpharm. VASCEPA (icosapent ethyl) - triglyceride level reduction.

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

  • Pharma deals during November 2012 Pharma deals during November 2012

    Pronova supplies the active ingredient in GSK's triglyceride lowering omega-3 drug Lovaza and, in addition, is developing competitor formulations – the most advanced being PRC-4016 for dyslipidaemia.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Channel purpose, change lives

    Ideas came to life through a multitude of means, from AstraZeneca’ s talking fish who discuss "love, life and triglycerides" to Cancer Council NSW’ s ‘ I Touch Myself Project’ that reinvented

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics